Stockreport

Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors
PDF Dr. Reddy’s becomes the first company to receive marketing authorization for generic Semaglutide Injection in CanadaThe market authorization was granted to Dr. Reddy’s a [Read more]